Literature DB >> 26416909

Mouse model for sublethal Leptospira interrogans infection.

Luciana Richer1, Hari-Hara Potula1, Rita Melo2, Ana Vieira2, Maria Gomes-Solecki3.   

Abstract

Although Leptospira can infect a wide range of mammalian species, most studies have been conducted in golden Syrian hamsters, a species particularly sensitive to acute disease. Chronic disease has been well characterized in the rat, one of the natural reservoir hosts. Studies in another asymptomatic reservoir host, the mouse, have occasionally been done and have limited infection to mice younger than 6 weeks of age. We analyzed the outcome of sublethal infection of C3H/HeJ mice older than age 10 weeks with Leptospira interrogans serovar Copenhageni. Infection led to bloodstream dissemination of Leptospira, which was followed by urinary shedding, body weight loss, hypothermia, and colonization of the kidney by live spirochetes 2 weeks after infection. In addition, Leptospira dissemination triggered inflammation in the kidney but not in the liver or lung, as determined by increased levels of mRNA transcripts for the keratinocyte-derived chemokine, RANTES, macrophage inflammatory protein 2, tumor necrosis factor alpha, interleukin-1β, inducible nitric oxide synthase, interleukin-6, and gamma interferon in kidney tissue. The acquired humoral response to Leptospira infection led to the production of IgG mainly of the IgG1 subtype. Flow cytometric analysis of splenocytes from infected mice revealed that cellular expansion was primarily due to an increase in the levels of CD4(+) and double-negative T cells (not CD8(+) cells) and that CD4(+) T cells acquired a CD44(high) CD62L(low) effector phenotype not accompanied by increases in memory T cells. A mouse model for sublethal Leptospira infection allows understanding of the bacterial and host factors that lead to immune evasion, which can result in acute or chronic disease or resistance to infection (protection).
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26416909      PMCID: PMC4645400          DOI: 10.1128/IAI.01115-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

2.  Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group.

Authors:  A I Ko; M Galvão Reis; C M Ribeiro Dourado; W D Johnson; L W Riley
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

3.  Proteomic analysis of Leptospira interrogans shed in urine of chronically infected hosts.

Authors:  Avril M Monahan; John J Callanan; Jarlath E Nally
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

4.  TLR4- and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans.

Authors:  Cécilia Chassin; Mathieu Picardeau; Jean-Michel Goujon; Pascale Bourhy; Nathalie Quellard; Sylvie Darche; Edgar Badell; Martine Fanton d'Andon; Nathalie Winter; Sonia Lacroix-Lamandé; Dominique Buzoni-Gatel; Alain Vandewalle; Catherine Werts
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

5.  Leptospirosis and the maintenance host: a laboratory mouse model.

Authors:  S C Hathaway; D K Blackmore; R B Marshall
Journal:  Res Vet Sci       Date:  1983-01       Impact factor: 2.534

6.  Carriage of Leptospira interrogans among domestic rats from an urban setting highly endemic for leptospirosis in Brazil.

Authors:  Marcos Tucunduva de Faria; Michael S Calderwood; Daniel A Athanazio; Alan J A McBride; Rudy A Hartskeerl; Martha Maria Pereira; Albert I Ko; Mitermayer G Reis
Journal:  Acta Trop       Date:  2008-07-31       Impact factor: 3.112

7.  Chemokines expression during Leptospira interrogans serovar Copenhageni infection in resistant BALB/c and susceptible C3H/HeJ mice.

Authors:  Josefa B da Silva; Tatiane M V Ramos; Marcelo de Franco; Delhi Paiva; Paulo Lee Ho; Elizabeth A L Martins; Martha M Pereira
Journal:  Microb Pathog       Date:  2009-05-19       Impact factor: 3.738

Review 8.  Leptospirosis: risks during recreational activities.

Authors:  A M Monahan; I S Miller; J E Nally
Journal:  J Appl Microbiol       Date:  2009-03-03       Impact factor: 3.772

9.  CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.

Authors:  Siobhán C Cowley; Elizabeth Hamilton; Jeffrey A Frelinger; Jie Su; James Forman; Karen L Elkins
Journal:  J Exp Med       Date:  2005-07-18       Impact factor: 14.307

10.  Leptospira Interrogans induces fibrosis in the mouse kidney through Inos-dependent, TLR- and NLR-independent signaling pathways.

Authors:  Martine Fanton d'Andon; Nathalie Quellard; Béatrice Fernandez; Gwenn Ratet; Sonia Lacroix-Lamandé; Alain Vandewalle; Ivo G Boneca; Jean-Michel Goujon; Catherine Werts
Journal:  PLoS Negl Trop Dis       Date:  2014-01-30
View more
  22 in total

1.  Eyedrop Inoculation Causes Sublethal Leptospirosis in Mice.

Authors:  Joseph Pierce Sullivan; Nisha Nair; Hari-Hara Potula; Maria Gomes-Solecki
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

Review 2.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

3.  Continuous Excretion of Leptospira borgpetersenii Ballum in Mice Assessed by Viability Quantitative Polymerase Chain Reaction.

Authors:  Marie-Estelle Soupé-Gilbert; Emilie Bierque; Sophie Geroult; Magali Teurlai; Cyrille Goarant
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

4.  Sex Matters: Male Hamsters Are More Susceptible to Lethal Infection with Lower Doses of Pathogenic Leptospira than Female Hamsters.

Authors:  Charles K Gomes; Mariana Guedes; Hari-Hara Potula; Odir A Dellagostin; Maria Gomes-Solecki
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

5.  A Mouse Model of Sublethal Leptospirosis: Protocols for Infection with Leptospira Through Natural Transmission Routes, for Monitoring Clinical and Molecular Scores of Disease, and for Evaluation of the Host Immune Response.

Authors:  Nisha Nair; Maria Gomes-Solecki
Journal:  Curr Protoc Microbiol       Date:  2020-12

6.  Pre-treatment with Lactobacillus plantarum prevents severe pathogenesis in mice infected with Leptospira interrogans and may be associated with recruitment of myeloid cells.

Authors:  Hari-Hara Potula; Luciana Richer; Catherine Werts; Maria Gomes-Solecki
Journal:  PLoS Negl Trop Dis       Date:  2017-08-25

7.  A new model of self-resolving leptospirosis in mice infected with a strain of Leptospira interrogans serovar Autumnalis harboring LPS signaling only through TLR4.

Authors:  Bili Xia; Le Sun; Xia Fan; Haihan Xiao; Yongzhang Zhu; Jinhong Qin; Chengsong Cai; Wei Zhao; Yung-Fu Chang; Yan Zhang; Xiaokui Guo; Ping He
Journal:  Emerg Microbes Infect       Date:  2017-05-24       Impact factor: 7.163

Review 8.  Animal Models of Leptospirosis: Of Mice and Hamsters.

Authors:  Maria Gomes-Solecki; Ignacio Santecchia; Catherine Werts
Journal:  Front Immunol       Date:  2017-02-21       Impact factor: 7.561

9.  Inflammatory Signatures of Pathogenic and Non-Pathogenic Leptospira Infection in Susceptible C3H-HeJ Mice.

Authors:  Advait Shetty; Suman Kundu; Maria Gomes-Solecki
Journal:  Front Cell Infect Microbiol       Date:  2021-06-24       Impact factor: 5.293

10.  Cytokine and Chemokine Expression in Kidneys during Chronic Leptospirosis in Reservoir and Susceptible Animal Models.

Authors:  Mariko Matsui; Louise Roche; Sophie Geroult; Marie-Estelle Soupé-Gilbert; Didier Monchy; Michel Huerre; Cyrille Goarant
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.